MedPath

Effect of Quetiapine in Preventing Delirium in ICU Patients

Phase 3
Conditions
patient admitted to the intensive care unit.
Delirium due to known physiological condition
Registration Number
IRCT20180520039739N5
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
98
Inclusion Criteria

Hospitalization in the intensive care unit
Age over 18 years
Patient satisfaction
No alcohol addiction
Healthy vision and hearing or elimination of vision and hearing defects by using glasses and hearing aids
No use of psychoactive drugs

Exclusion Criteria

head trauma
QT prolongation
Encephalopathy
Basal systolic blood pressure above 140
Basal diastolic blood pressure above 90
Tachycardia (beats more than 100 per minute)
History of seizures
Hypersensitivity to quetiapine
intubated patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium Frequency. Timepoint: every 8 hours. Method of measurement: The number of episodes of delirium observed in an 8-hour period. This variable measures how often delusions occur in each group And it is measured using the Neecham criterion.;Severity of delirium. Timepoint: every 8 hours. Method of measurement: The intensity or severity of delirium symptoms experienced by participants was measured using the Neecham scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath